{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:59:18Z","timestamp":1793908758493,"version":"4.8.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ijantimicag.2019.03.024","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T02:23:25Z","timestamp":1554431005000},"page":"709-715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Repurposing disulfiram for treatment of Staphylococcus aureus infections"],"prefix":"10.1016","volume":"53","author":[{"given":"Ritesh","family":"Thakare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjulika","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunava","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8823-6074","authenticated-orcid":false,"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0001","unstructured":"World Health Organization. Antimicrobial resistance. Geneva: WHO. Available at:www.who.int\/antimicrobial-resistance\/en\/."},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0002","unstructured":"Infectious Diseases Society of America. Antibiotic Development: The 10 x '20 initiative. Arlington, VA: IDSA. Available at:https:\/\/www.idsociety.org\/10x20\/."},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0003","unstructured":"World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed. Geneva: WHO. Available at:http:\/\/www.who.int\/news-room\/detail\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed."},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0004","unstructured":"World Economic Forum. Antimicrobial resistance. Cologny: WEF. Available at:reports.weforum.org\/global-risks-2018\/anti-microbial-resistance\/."},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0005","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0006","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1517\/13543784.15.11.1295","article-title":"Complementary new approaches enable repositioning of failed drug candidates","volume":"15","author":"Tartaglia","year":"2006","journal-title":"Exp Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0007","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2217\/fmb-2016-0021","article-title":"Drug repurposing: a new front in the war against Staphylococcus aureus","volume":"11","author":"Das","year":"2016","journal-title":"Fut Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0008","unstructured":"Drugbank. Disulfiram. Drugbank. Available at:https:\/\/www.drugbank.ca\/drugs\/DB00822."},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0009","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1128\/AAC.06445-11","article-title":"Anti-tubercular activity of disulfiram, an anti-alcoholism drug, against multi-drug and extensively drug-resistant Mycobacterium tuberculosis isolates","volume":"56","author":"Horita","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0010","first-page":"61","article-title":"Repurposing thiram and disulfiram as antibacterial agents for multidrug-resistant Staphylococcus aureus infections","volume":"24","author":"Long","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0011","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/AAC.35.4.785","article-title":"Disulfiram inhibits the in vitro growth of methicillin-resistant Staphylococcus aureus","volume":"35","author":"Phillips","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0012","series-title":"Performance standards for antimicrobial susceptibility testing; Twenty-First informational supplement. CLSI document M100-S21","year":"2012"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0013","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/bjc.1987.190","article-title":"A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity","volume":"56","author":"Twentyman","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0014","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijantimicag.2017.03.020","article-title":"Repurposing ivacaftor for treatment of Staphylococcus aureus infections","volume":"50","author":"Thakare","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0016","first-page":"Unit 13A.8","article-title":"Static biofilm cultures of Gram-positive pathogens grown in a microtiter format used for anti-biofilm drug discovery","volume":"Chapter 13","author":"Kwasny","year":"2010","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0017","doi-asserted-by":"crossref","first-page":"22571","DOI":"10.1038\/srep22571","article-title":"Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens","volume":"6","author":"Thangamani","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0018","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1046\/j.1365-2672.2002.01594.x","article-title":"The antibacterial activity of vancomycin towards Staphylococcus aureus under aerobic and anaerobic conditions","volume":"92","author":"Suller","year":"2002","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0019","first-page":"171","article-title":"In vitro antimicrobial activity of diethyldithiocarbamate and dimethyldithiocarbamate against methicillin-resistant Staphylococcus","volume":"17","author":"Taylor","year":"1987","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0020","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1001\/jama.293.24.3012","article-title":"Staphylococcus aureus endocarditis: a consequence of medical progress","volume":"293","author":"Fowler","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2019.03.024_bib0021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0447.1992.tb03310.x","article-title":"A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites","volume":"369","author":"Johansson","year":"1992","journal-title":"Acta Psychiatr Scand Suppl"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791930086X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791930086X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:32:06Z","timestamp":1760376726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791930086X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S092485791930086X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.03.024","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing disulfiram for treatment of Staphylococcus aureus infections","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}